ERI Thresholds Between Adjacent Zones. by Mingyue Sun (4638535)

Location of the study area. by Mingyue Sun (4638535)

Random Forest structure with cross-validation. by Mingyue Sun (4638535)

Land use change from 1990 to 2020. by Mingyue Sun (4638535)

Geographic data. by Mingyue Sun (4638535)

Classification accuracy. by Mingyue Sun (4638535)

RES females have target site and metabolic resistance mechanisms. by Kelsey L. Adams (12859609)

Maximum neutralization activity of bnMAbs in a TZM-bl target cell assay. by Laura E. McCoy (386535)

“…<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of MPN. …”

Pre-diabetes is associated with increased risk of heart failure among patients with atrial fibrillation by Jia-Yi Huang (12733928)

“…</p> <p><strong>Results</strong>: Among 17,943 AF patients (mean age 75.5 years, 47% female), 3,711 (20.7%) had pre-diabetes and 10,127 (56.4%) had diabetes at baseline. …”

USP22 lentiviral shRNA vectors. by Xianghong Kuang (17811238)

“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”

Antibodies. by Xianghong Kuang (17811238)

“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”

qRT-PCR primers. by Xianghong Kuang (17811238)

“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”

Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... by Lívia Pimenta Bonifácio (7502579)

“…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”

FABP5 expression modulates PPAR-γ activity. by Fabienne Gally (260470)

“…<p><b>A.</b> FABP5 down regulation significantly decreases PPAR-γ activity in primary NHBE cell cultures. …”

Knockdown of IFI27 impairs the proliferation of EBV-infected B cells during de novo infection. by Ken Sagou (1945318)

Expression levels of ERBB2 and ER⍺ proteins and incidence of lung metastases in <i>Usp22</i> ^<i>OE/OE</i>- NIC mice. by Xianghong Kuang (17811238)

A. We randomly selected 20 mutually exclusive groups of protein complexes that contained exactly five subunits; we mapped the corresponding gene pairs to SINaTRA scores, and plotte... by Alexandra Jacunski (5665486)

“…We compared the fraction of gene pairs with products in the same vs. different complexes for three SINaTRA cutoffs (0.95, 0.80, 0.50) as well as for all gene pairs. A SINaTRA cutoff of 0.95 has approximately half of its pairs associated with the same complex; however, a decrease in the cutoff shifts this balance. …”

Expression levels of <i>Nr3c1</i> (glucocorticoid receptor), <i>Pgr</i> (progesterone receptor) and <i>Smarca4 (</i>BRG1<i>)</i> upon loss of <i>Usp22</i>. by Xianghong Kuang (17811238)

Delayed tumor formation upon conditional deletion of <i>Usp22</i> in mammary gland epithelial cells in MMTV-NIC mice. by Xianghong Kuang (17811238)

Overexpression of USP22 does not augment mammary gland tumor formation in MMTV-NIC mice. by Xianghong Kuang (17811238)